Jazz Pharmaceuticals plc Other Assets, Miscellaneous, Current
Jazz Pharmaceuticals plc (JAZZ) had Other Assets, Miscellaneous, Current of $140.11 million as of 2024-06-30, per its 10-Q filed 2024-08-01.
Discontinued › Notes
us-gaap:OtherAssetsMiscellaneousCurrent · last filed 2024-08-01
- 2024-06-30: Other Assets, Miscellaneous, Current $140.11M.
- 2024-03-31: Other Assets, Miscellaneous, Current $135.85M.
- 2023-12-31: Other Assets, Miscellaneous, Current $149.30M.
- 2023-09-30: Other Assets, Miscellaneous, Current $101.39M.
| Period end | Other Assets, Miscellaneous, Current |
|---|---|
| 2024-06-30 | $140.11M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $135.85M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $149.30M 10-Q · filed 2024-08-01 |
| 2023-09-30 | $101.39M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $72.81M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $57.22M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $91.14M 10-K · filed 2024-02-28 |
| 2022-09-30 | $45.36M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $50.58M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $38.66M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $48.91M 10-K · filed 2023-03-01 |
| 2021-09-30 | $41.27M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $39.37M 10-Q · filed 2021-08-03 |
| 2020-12-31 | $38.26M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |